Dr Reddys Laboratories (RDY) Change in Receivables (2009 - 2011)
Dr Reddys Laboratories (RDY) posted Change in Receivables of -$40.0 million for Q3 2011, down 227.73% on a QoQ basis from $31.3 million in Q2 2011, and down 116.06% year-over-year from $249.0 million in Q3 2010.
Analysis
Dr Reddys Laboratories (RDY) Change in Receivables (2009 - 2011) Analysis & Trends
Dr Reddys Laboratories has reported Change in Receivables for 3 years, with the latest figure at -$40.0 million in Q3 2011.
- On a quarterly basis, Change in Receivables fell 116.06% year-over-year to -$40.0 million in Q3 2011; TTM through Sep 2011 was -$29.7 million, a 344.44% decrease from a year earlier, with the FY2026 full-year figure at -$72.0 million, up 40.0% from the prior year.
- Change in Receivables was -$40.0 million for Q3 2011 at Dr Reddys Laboratories, down from $31.3 million in the prior quarter.
- The five-year high for Change in Receivables was $31.3 million in Q2 2011, with the low at -$40.0 million in Q3 2011.
- Average Change in Receivables over 3 years is -$1.1 million, with a median of $2.3 million recorded in 2009.
- The sharpest annual moves came in 2010 and 2011: Change in Receivables slumped 359.74% in 2010, then jumped 1360.02% in 2011.
- Over 3 years, Change in Receivables stood at $26.0 million in 2009, then tumbled by 171.17% to -$18.5 million in 2010, then slumped by 116.06% to -$40.0 million in 2011.
- The last three Change in Receivables figures came in at -$40.0 million (Q3 2011), $31.3 million (Q2 2011), and -$18.5 million (Q3 2010), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn | 91.00 Mn |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn | 126.50 Mn |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn | 169.78 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 70.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 1.24 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 19.08 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | -2.98 Mn |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | -39.98 Mn |
| Jun 30, 2011 | 31.30 Mn |
| Sep 30, 2010 | -18.50 Mn |
| Jun 30, 2010 | -2.48 Mn |
| Dec 31, 2009 | 26.00 Mn |
| Sep 30, 2009 | 7.12 Mn |
| Jun 30, 2009 | 12.00 Mn |
| Mar 31, 2009 | -24.22 Mn |